H.R. 9418 · House bill · 119th Congress

Access to Innovative Treatments Act of 2026

Sponsored by Rep. Nanette Barragán, California with 1 co-sponsor

Introduced Jun 24, 2026

Referred to the Energy and Commerce Committee

Latest action Jun 24, 2026

SponsorRep. Nanette Barragán, California· 1 cosponsorRep. John Joyce, Pennsylvania

What the bill does

This bill requires the Centers for Medicare & Medicaid Services (CMS) to review adverse national coverage determinations of drugs under Medicare within 30 days of receiving a request to do so.

Summary by the Congressional Research Service, Jul 14, 2026.

BillFull text · congress.gov(opens in a new tab)

Read the bill

The text of this bill isn’t available to show here yet. Read it on Congress.gov (opens in a new tab)